Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 7:14:1121285.
doi: 10.3389/fimmu.2023.1121285. eCollection 2023.

Diversity of immune checkpoints in cancer immunotherapy

Zhangyan Guo  1 , Rui Zhang  1   2 , An-Gang Yang  1 , Guoxu Zheng  1
Affiliations
Review

Diversity of immune checkpoints in cancer immunotherapy

Zhangyan Guo et al. Front Immunol. .

Abstract

Finding effective treatments for cancer remains a challenge. Recent studies have found that the mechanisms of tumor evasion are becoming increasingly diverse, including abnormal expression of immune checkpoint molecules on different immune cells, in particular T cells, natural killer cells, macrophages and others. In this review, we discuss the checkpoint molecules with enhanced expression on these lymphocytes and their consequences on immune effector functions. Dissecting the diverse roles of immune checkpoints in different immune cells is crucial for a full understanding of immunotherapy using checkpoint inhibitors.

Keywords: NK cell; T cell; immune checkpoint; immunotherapy; macrophage.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Different immune checkpoint molecules expressed on different immune cells. (A) Different immune checkpoint molecules expressed on T cell and the corresponding ligand molecules expressed on tumor cells. (B) Different immune checkpoint molecules expressed on NK cell and the corresponding ligand molecules expressed on tumor cells. (C) Different immune checkpoint molecules expressed on Macrophage and the corresponding ligand molecules expressed on tumor cells. (D) Different immune checkpoint molecules expressed on dendritic cell and the corresponding ligand molecules expressed on tumor cells.
Figure 2
Figure 2
Different ICs expressing on different lymphocytes and and the targeted blocking antibody.
See this image and copyright information in PMC

References

    1. Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer (2012) 12(4):252–64. doi: 10.1038/nrc3239 - DOI - PMC - PubMed
    1. Bagchi S, Yuan R, Engleman EG. Immune checkpoint inhibitors for the treatment of cancer: Clinical impact and mechanisms of response and resistance. Annu Rev Pathol (2021) 16:223–49. doi: 10.1146/annurev-pathol-042020-042741 - DOI - PubMed
    1. Zhang Y, Zheng J. Functions of immune checkpoint molecules beyond immune evasion. Adv Exp Med Biol (2020) 1248:201–26. doi: 10.1007/978-981-15-3266-5_9 - DOI - PubMed
    1. Qin S, Xu L, Yi M, Yu S, Wu K, Luo S. Novel immune checkpoint targets: Moving beyond pd-1 and ctla-4. Mol Cancer (2019) 18(1):155. doi: 10.1186/s12943-019-1091-2 - DOI - PMC - PubMed
    1. Khan M, Arooj S, Wang H. Nk cell-based immune checkpoint inhibition. Front Immunol (2020) 11:167. doi: 10.3389/fimmu.2020.00167 - DOI - PMC - PubMed

Publication types